JP4262094B2 - 新規製剤およびその使用 - Google Patents
新規製剤およびその使用 Download PDFInfo
- Publication number
- JP4262094B2 JP4262094B2 JP2003530292A JP2003530292A JP4262094B2 JP 4262094 B2 JP4262094 B2 JP 4262094B2 JP 2003530292 A JP2003530292 A JP 2003530292A JP 2003530292 A JP2003530292 A JP 2003530292A JP 4262094 B2 JP4262094 B2 JP 4262094B2
- Authority
- JP
- Japan
- Prior art keywords
- nicotine
- chocolate
- base
- oral
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
- A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Description
5〜10分後にピークの血中レベルに達する。したがって、これら慣用のニコチン送達のデバイスおよび方法の不利な点を回避し、一方、禁煙治療のため、ニコチン渇望を減少させるため、およびニコチン療法に対応するその他の状態を治療するためにニコチンを送達するのに有効な手段を提供する改良された組成物および方法を提供することが所望されている。
コチンを含有する該組成物を提供することである。本出願での「口腔(buccal)」は、「口腔内、またはその他の口腔中粘膜による摂取について」を意味する。
本発明の第一の目的は、許容されない有害な作用を惹起せずにタバコ禁断症候群を減少させるように、十分な投与量のニコチンをユーザーに提供する、例えば禁煙およびニコチン代替療法で使用するためのタバコ補助品およびタバコ代用品を提供することにある。さらに詳しく言えば、本発明の目的は、ニコチン含有錠剤であって、唾液流体または機械的侵食またはそれらの組み合わせを用いるかまたは用いないで、該製剤が好ましくは口腔中の組織への接着性を好適に示してから体温で崩壊および/または融解する、経粘膜好ましくは口腔送達用の該錠剤を提供することにある。
1)
ニコチン(塩基または酒石酸水素塩として):塩基として測定して1〜6mg、
炭酸ナトリウム: 約15mg、
ブラックチョコレート: 十分量
2)
ニコチン(塩基または酒石酸水素塩として):塩基として測定して1〜6mg、
炭酸ナトリウム: 約15mg、
ホワイトチョコレート: 十分量、 または
3)
ニコチン(塩基または酒石酸水素塩として):塩基として測定して1〜6mg、
炭酸ナトリウム: 約15mg、
ミルクチョコレート: 十分量、
を有し、口内で融解する約400mgの錠剤である。
以下の好適な組成(w/w)
活性成分: ニコチン(塩基または塩、好ましくは酒石酸水素塩)塩基として測定して
1〜6mg、ニコチンは、例えば陽イオン交換樹脂またはシクロデキストリと一緒になって複合体で存在してもよい。
バッファー剤: 炭酸ナトリウム 約15mg
ビヒクル: チョコレート 十分量
を有する約400mgの錠剤は、下記のようにして調製された。
有用な態様は、前記賦形剤のいくつかを同等に機能する別の化合物に変換することにより得られた。
バッファーの炭酸ナトリウムは、例えば、ナトリウム、カリウムもしくはアンモニウムの炭酸塩、重炭酸塩、リン酸塩、グリシン酸塩、グルコン酸塩もしくはグリセロリン酸塩またはそれらの混合物と交換してもよい。しかし、多くのリン酸塩はさほど適切ではない。その理由は、通常、それらの味が不快であり、しかも遮蔽が困難であるからである。
活性成分: ニコチン(塩基または塩好ましくは酒石酸水素塩として)塩基として測定して 約0.5mg〜約10mg、
バッファー剤: 約5mg〜約40mg、
ビヒクル: チョコレート 十分量
のような、単位投与量当たりの製剤の各成分の一定の濃度範囲内で得ることができた。
場合により、矯味矯臭剤例えばミント、コーヒー、オレンジ、バニラおよびミルク−バタースコッチを添加してもよい。
の装置であるのがよい。
Claims (3)
- ニコチン含有医薬組成物であって、組成物400mg当たり、
ニコチン: 塩基として測定して、0.5mg〜10mg、
バッファー剤: 5mg〜40mg、
チョコレートビヒクル: 350mg〜394.5mg
からなり、バッファー剤が、ナトリウム、カリウムもしくはアンモニウムの炭酸塩、重炭酸塩、リン酸塩、グリシン酸塩、酢酸塩、グルコン酸塩もしくはグリセロリン酸塩またはそれらの混合物から選択され、そして経口剤形として処方され、口腔粘膜を経由してニコチンを送達する、
ことを特徴とする、ニコチン含有医薬組成物。 - 塩基として測定してニコチン1〜6mg、チョコレート95%(w/w)および炭酸ナトリウム15mgからなることを特徴とする、請求項1に記載のニコチン含有医薬組成物。
- 一種またはそれ以上の、ミント、コーヒー、オレンジ、バニラおよびミルクバタースコッチのような矯味矯臭剤をさらに含有することを特徴とする、請求項1または2に記載のニコチン含有医薬組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103210A SE0103210D0 (sv) | 2001-09-27 | 2001-09-27 | New formulations and use thereof |
PCT/SE2002/001612 WO2003026656A1 (en) | 2001-09-27 | 2002-09-10 | New formulations and use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005503429A JP2005503429A (ja) | 2005-02-03 |
JP2005503429A5 JP2005503429A5 (ja) | 2005-12-22 |
JP4262094B2 true JP4262094B2 (ja) | 2009-05-13 |
Family
ID=20285456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003530292A Expired - Fee Related JP4262094B2 (ja) | 2001-09-27 | 2002-09-10 | 新規製剤およびその使用 |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1429770B1 (ja) |
JP (1) | JP4262094B2 (ja) |
KR (1) | KR20040047868A (ja) |
CN (1) | CN1561213A (ja) |
AR (1) | AR036679A1 (ja) |
AT (1) | ATE431144T1 (ja) |
AU (1) | AU2002334523B2 (ja) |
BR (1) | BR0212834A (ja) |
CA (1) | CA2461757C (ja) |
DE (1) | DE60232344D1 (ja) |
DK (1) | DK1429770T3 (ja) |
ES (1) | ES2325684T3 (ja) |
IL (1) | IL160886A0 (ja) |
MX (1) | MXPA04002876A (ja) |
NZ (1) | NZ532528A (ja) |
RU (1) | RU2282447C2 (ja) |
SE (1) | SE0103210D0 (ja) |
WO (1) | WO2003026656A1 (ja) |
ZA (1) | ZA200402091B (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
BRPI0415741B1 (pt) | 2003-11-07 | 2013-07-23 | composições de tabaco e métodos de fabricação de uma composição de tabaco | |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
CZ200980A3 (cs) * | 2009-02-11 | 2010-04-28 | Heglund A.S. | Kompozice urcená k bukální absorpci nikotinu za úcelem odvykání kourení |
RU2453754C1 (ru) * | 2010-12-27 | 2012-06-20 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования Сибирский федеральный университет (СФУ) | Устройство для бестраншейной замены трубопроводов |
RU2448573C1 (ru) * | 2010-12-27 | 2012-04-27 | Олег Иванович Квасенков | Способ получения некурительного изделия из махорки |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8404808L (sv) * | 1983-10-03 | 1985-04-04 | Avner Rotman | Mikrokapslat lekemedel i sot matris |
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
SE9803986D0 (sv) * | 1998-11-23 | 1998-11-23 | Pharmacia & Upjohn Ab | New compositions |
SE0103211D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
-
2001
- 2001-09-27 SE SE0103210A patent/SE0103210D0/xx unknown
-
2002
- 2002-09-10 BR BR0212834-9A patent/BR0212834A/pt not_active IP Right Cessation
- 2002-09-10 DK DK02799531T patent/DK1429770T3/da active
- 2002-09-10 ES ES02799531T patent/ES2325684T3/es not_active Expired - Lifetime
- 2002-09-10 CA CA002461757A patent/CA2461757C/en not_active Expired - Lifetime
- 2002-09-10 AT AT02799531T patent/ATE431144T1/de not_active IP Right Cessation
- 2002-09-10 RU RU2004108853/15A patent/RU2282447C2/ru not_active IP Right Cessation
- 2002-09-10 EP EP02799531A patent/EP1429770B1/en not_active Expired - Lifetime
- 2002-09-10 NZ NZ532528A patent/NZ532528A/en not_active IP Right Cessation
- 2002-09-10 KR KR10-2004-7004483A patent/KR20040047868A/ko not_active Application Discontinuation
- 2002-09-10 WO PCT/SE2002/001612 patent/WO2003026656A1/en active IP Right Grant
- 2002-09-10 MX MXPA04002876A patent/MXPA04002876A/es active IP Right Grant
- 2002-09-10 CN CNA028190386A patent/CN1561213A/zh active Pending
- 2002-09-10 DE DE60232344T patent/DE60232344D1/de not_active Expired - Lifetime
- 2002-09-10 IL IL16088602A patent/IL160886A0/xx unknown
- 2002-09-10 AU AU2002334523A patent/AU2002334523B2/en not_active Ceased
- 2002-09-10 JP JP2003530292A patent/JP4262094B2/ja not_active Expired - Fee Related
- 2002-09-26 AR ARP020103631A patent/AR036679A1/es unknown
-
2004
- 2004-03-16 ZA ZA2004/02091A patent/ZA200402091B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR036679A1 (es) | 2004-09-29 |
RU2282447C2 (ru) | 2006-08-27 |
DE60232344D1 (de) | 2009-06-25 |
ES2325684T3 (es) | 2009-09-14 |
AU2002334523B2 (en) | 2007-02-15 |
RU2004108853A (ru) | 2005-04-20 |
IL160886A0 (en) | 2004-08-31 |
NZ532528A (en) | 2005-10-28 |
CA2461757C (en) | 2008-09-02 |
CA2461757A1 (en) | 2003-04-03 |
CN1561213A (zh) | 2005-01-05 |
MXPA04002876A (es) | 2005-06-20 |
JP2005503429A (ja) | 2005-02-03 |
EP1429770B1 (en) | 2009-05-13 |
WO2003026656A1 (en) | 2003-04-03 |
ATE431144T1 (de) | 2009-05-15 |
DK1429770T3 (da) | 2009-08-03 |
EP1429770A1 (en) | 2004-06-23 |
SE0103210D0 (sv) | 2001-09-27 |
BR0212834A (pt) | 2004-10-13 |
ZA200402091B (en) | 2005-06-29 |
KR20040047868A (ko) | 2004-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101414063B1 (ko) | 완충제로서 트로메타몰을 포함하는, 니코틴의 구강내 전달을 위한 피복된 약제학적 제품 | |
JP2010006845A (ja) | 新規の配合物及びその使用 | |
JP5710121B2 (ja) | トロメタモールを緩衝性作用物質として含有する、ニコチンの口腔内送り込み用薬用製品 | |
US6676959B1 (en) | Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption | |
US20070122458A1 (en) | Nicotine and Chocolate Compositions | |
US20080286341A1 (en) | Buffered coated nicotine containing products | |
BR112020011238A2 (pt) | Formulação de nicotina oral sólida para alívio de desejo de nicotina de início rápido, formulação de nicotina oral sólida para uso na atenuação do desejo de nicotina, método de atenuação do desejo de nicotina e bolsa oral | |
US20100124560A1 (en) | Multi portion intra-oral dosage form and use thereof | |
JP2012505878A (ja) | 複数部分口内剤形及びその使用 | |
JP7278281B2 (ja) | ニコチン錠 | |
KR20100108307A (ko) | 감각수용 특성을 갖는 다중 부분 경구내 투여 형태 | |
JP2004525928A (ja) | ニコチン含有経口剤形 | |
CN110621307A (zh) | 含有烟碱的口香糖组合物 | |
JP2006503046A (ja) | 放出が改変された経口製剤 | |
Renu et al. | Chewable tablets: a comprehensive review | |
JP4262094B2 (ja) | 新規製剤およびその使用 | |
AU2002334523A1 (en) | New formulations and use thereof | |
Allen Jr | Formulation of Specialty Tablets for Slow Oral Dissolution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20071109 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080304 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080604 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080701 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081029 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20081216 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090120 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090206 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120220 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120220 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130220 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130220 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140220 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |